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Abstract
Background: The Vaccine Assessment using Linked Data (VALiD) trial compared opt-in and opt-out parental
consent for a population-based childhood vaccine safety surveillance program using data linkage. A subsequent
telephone interview of all households enrolled in the trial elicited parental intent regarding the return or non-
return of reply forms for opt-in and opt-out consent. This paper describes the rationale for the trial and provides
an overview of the design and methods.
Methods/Design: Single-centre, single-blind, randomised controlled trial (RCT) stratified by firstborn status. Mothers
who gave birth at one tertiary South Australian hospital were randomised at six weeks post-partum to receive an
opt-in or opt-out reply form, along with information explaining data linkage. The primary outcome at 10 weeks
post-partum was parental participation in each arm, as indicated by the respective return or non-return of a reply
form (or via telephone or email response). A subsequent telephone interview at 10 weeks post-partum elicited
parental intent regarding the return or non-return of the reply form, and attitudes and knowledge about data
linkage, vaccine safety, consent preferences and vaccination practices. Enrolment began in July 2009 and 1,129
households were recruited in a three-month period. Analysis has not yet been undertaken. The participation rate
and selection bias for each method of consent will be compared when the data are analysed.
Discussion: The VALiD RCT represents the first trial of opt-in versus opt-out consent for a data linkage study that
assesses consent preferences and intent compared with actual opting in or opting out behaviour, and
socioeconomic factors. The limitations to generalisability are discussed.
Trial registration: Australian New Zealand Clinical Trials Registry ACTRN12610000332022
Background
Options for consent that are available for health and
medical research involving human subjects are: no con-
sent, using either identifiable or non-identifiable data;
opt-in consent, where each person is informed about the
research and their consent is sought; and opt-out con-
sent, where each person is informed about the research
and included unless they indicate an unwillingness to
participate [1]. A request for consent may be either
project-specific, extended (for future research projects)
or broad authorisation for research use [2]. Under the
opt-in approach, the subject’s failure to act leads to
non-inclusion; but ‘non-participation’ may not stem
from a meaningful decision and may reflect a lack of
contemplation or intention [3]. Under the opt-out
approach, inclusion in research may largely depend on
individuals’ inertia; therefore, the true proportion of
people who do not wish to participate may be under-
stated [4].
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Conduct in Human Research [2] guides Human Research
Ethics Committees (HRECs) to require opt-in consent
under most circumstances. However, health information
can be used in the conduct of specific activities (includ-
ing research of various types) without a subject’sp e r -
mission ‘provided an assessment is made by an HREC
that the research and other activities are, on balance,
substantially in the public interest’ [5]. Data linkage is
one such specific activity [2], defined as ‘the bringing
together, from two or more different sources, data that
relate to the same individual, family, place or event’ [6].
The development in recent decades of integrated
electronic administrative healthcare databases has
enabled sophisticated and powerful population-level data
linkage studies on the factors influencing health and well-
being, and health services evaluation [7-10]. Privacy
advocates have perceived these developments as a poten-
tial threat to privacy, sparking an increase in the rigour
and complexity of the privacy framework in Australia
and associated regimens of HREC submissions
[5,8,11-14]. Threats to privacy are minimised when data
linkage adheres to the best practice protocol [15],
whereby strict separation of individual demographic
identifiers from clinical health information is maintained
during and after the linkage process, ensuring researchers
never receive personal identifiers and data custodians
never exchange identifiable health data [6,15]. Despite
the availability of privacy-conserving linkage protocols,
some data custodians still require each individual’s opt-in
consent for release of data [11,16], with severe adverse
consequences for the quality and validity of research.
Holman et al. suggest that when a system of consent
leads to participation rates of less than 90%, the informa-
tion available for the research becomes biased [11].
Several cross-sectional surveys and focus groups con-
ducted internationally [17-22] and in Australia [5,23]
have shown that the public has a strong preference to
be asked for consent for health and medical research,
including for data linkage studies [5,20,22]. There are
some notable exceptions: in two cross-sectional surveys
conducted in the United Kingdom [24] and Australia
[25], the majority of the public did not consider the
inclusion of identifiable health data in a cancer registry
and birth defects registry without consent to be an inva-
sion of privacy and expressed support for statutory case
registration. In terms of consent to data linkage, there
are no studies that have compared the numbers and
characteristics of participants enlisted under opt-in and
opt-out conditions using a well-designed Randomised
Controlled Trial (RCT). While there are RCTs that
relate to other aspects of medical research [26-30],
the extent of participation has varied widely, ranging
from 48%-85% in the opt-in arm and 59%-100% in the
opt-out arm, and all but one [28] had a small sample
size or flawed methodology [26,27,29,30] (Table 1). Only
two RCTs [26,30] are relevant to data linkage in that
participation required no effort on the part of the sub-
ject in terms of clinic attendance or involvement in dis-
ease screening, and there were no follow-up reminders,
which are not economically or logistically feasible for
large population-level studies [11].
There has been relatively little research on non-
participants in RCTs because of problems in obtaining
ethical approval [31,32]. Only two RCTs have elicited
the intent behind the return or non-return of forms for
subjects in the opt-in and opt-out trial arms by means
of a face-to-face interview [27], or postal and telephone
survey [30]. We designed a large RCT of opt-in and
opt-out consent for a proposed data linkage study into
adverse events following immunisation. All eligible
subjects were included in the RCT without their prior
consent being sought, which necessitated a consent
waiver from the approving HREC. Our justification for
not obtaining consent was that if prior consent were
sought it would lead to a selection bias in the study
sample. In order to study reasons for participation and
non-participation, we followed up the trial with a tele-
phone interview aimed at all randomised subjects,
whether or not they had indicated consent to the data
linkage study.
Purpose
Primary objective and hypotheses
To determine which method of obtaining parental con-
sent (opt-in or opt-out) provided the highest participa-
tion rate for a population-based childhood vaccine
safety surveillance program using data linkage.
The following Null hypotheses will be tested:
(1) There is no difference in the participation rate for
the opt-in and opt-out method, that is, the proportion
of parents who opt in by return of a reply form (or tele-
phoning or email) and the proportion who do not opt
out.
(2) Neither the opt-in nor opt-out method of consent
will result in parental participation greater than 90%.
Secondary objective and hypotheses
To examine consent preferences, and attitudes and
knowledge about vaccine safety, data linkage and vacci-
nation practices by means of a structured telephone
interview of all randomised subjects.
The following Null hypotheses will be tested:
(1) There are no differences in the motivations and bar-
riers given for the return/non-return of the reply form by
subjects who consented, or did not consent, in the opt-in
arm compared with subjects in the opt-out arm.
(2) There are no differences in consent preferences,
and attitudes and knowledge about vaccine safety, data
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Page 2 of 10Table 1 RCTs of opt-in and opt-out consent
Study
population
and
purpose
Parents in a health
district of the UK were
asked for consent for
inclusion of low birth-
weight infants on a
register for the
purpose of monitoring
disability in children
[26]
Mothers in the US were
asked for consent for
inclusion of infants at
high risk to participate
in a clinical trial of
primary follow-up care
[27]
Angina patients in
two general
practices in the UK
were asked for
consent to be
involved in clinical
research [28]
Patients aged 50-74
years in a general
practice in Australia
were asked to consent
to testing decision aids
for the screening of
colorectal cancer [29]
Cancer patients in the
Netherlands who had
undergone primary
surgery were asked for
consent for the storage
of excised tissue for
future research
purposes [30]
Sample size
randomised
(n)
Opt-in: 39
Opt-out: 30
Opt-in: 32
Opt-out: 25 (3 were
excluded as they did not
receive the allocated
intervention)
Opt-in: 252
Opt-out: 258
Opt-in: 92
Opt-out: 60
Opt-in: 60
’Opt-out plus’:7 3
Control group (standard
opt-out): 131
Mode of
invitation
Verbal information, letter
and reply slip given by a
nurse prior to an infant’s
discharge from hospital
Verbal information and
reply form given by a
nurse within 24-48 hours
of delivery. The opt-out
form was shortened to
include only specific
disclosures that are
appropriate for low risk
research
Letter, information
leaflet and reply card
sent from a doctor
Letter sent from a doctor
(plus reply card for the
opt-in arm only)
Verbal information,
specific information leaflet
and reply form given by
a doctor/nurse. The
control group was only
given a routine hospital
leaflet and did not
receive verbal information
Mode of
response
Reply-paid slip Reply form was collected
from the mother
Reply card or
telephone
Telephone or email (or
reply-paid card for the
opt-in arm)
Reply-paid form. The
control group leaflet
instructed patients to opt
out by informing their
doctor
Reminder
letter
No No After two weeks for
the opt-in arm only
No No
Time to
respond
Not stated Prior to discharge from
hospital. Once a mother
reached a decision, an
interview occurred within
the next 24 hours
(usually 2 hours)
Opt-in: Not stated
Opt-out: patients
could opt out verbally
when telephoned after
two weeks
Not stated One month
Participation
rate
Opt-in: 79%
Opt-out: 97%
Opt-in: 75%
Opt-out: 91%
Opt-in: 48%
Opt-out: 59%
Opt-in: 51%
Opt-out: 90%
Opt-in: 85%
’Opt-out plus’: 97%
Standard opt-out: 100%
Recruitment
rate
Not applicable Face-to-face interview
Opt-in: 81%
Opt-out: 82%
Clinic attendance
Opt-in: 38%
Opt-out: 50%
Telephone survey
Opt-in: 47%
Opt-out: 67%
Postal and telephone
survey
Opt-in: 93% and 52%
’Opt-out plus’: 93% and
51%
Standard opt-out: 88%
and 47%
Evidence of
selection
bias
Not stated Modest differences were
found. Subjects recruited
in the opt-in arm were
older, more likely to be
married and undergo a
vaginal delivery than
subjects in the opt-out
arm
Subjects recruited in
the opt-in arm were
healthier and had less
risk factors for
coronary disease than
subjects in the opt-out
arm
Subjects recruited in the
opt-in arm were more
likely to prefer an active
role in decision making
than subjects in the opt-
out arm
Subjects recruited in the
opt-in arm were similar in
age, sex, education and
type of cancer to the
‘opt-out plus’ arm. The
control group was similar,
except that women were
over-represented
Design flaws Small sample size, non-
random allocation and
no mention of whether
blinding was used
Small sample size and
the collection of reply
forms is resource-
intensive and
impracticable on a large
scale
None evident Small sample size and
non-parallel design
Small sample size and no
mention of whether
blinding was used
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subjects who consented, or did not consent, in the
opt-in arm compared with subjects in the opt-out arm.
Methods and Design
Study design and flow
This was a single-centre, stratified (firstborn versus
subsequent births), single-blind, parallel-group RCT con-
ducted in the Women’sa n dC h i l d r e n ’s Hospital (WCH),
a tertiary referral centre in metropolitan Adelaide, the
capital city of South Australia (SA) with a population of
about 1.19 million in 2009 [33]. Approximately 25% of all
South Australian babies are delivered at the hospital [34].
The study population consisted of parent(s) of every con-
secutive child born in a three-month period: from July
27, 2009, to October 25, 2009, inclusive. Data listings of
eligible live births were provided by the SA Department
of Health (SA Health) utilising the electronic patient
management system (HOMER™). The RCT received ethi-
cal approval from the Children, Youth and Women’s
Health Service (CYWHS) HREC (Reference: REC2087/7/
11) who granted a waiver of the usual requirement of
individual, fully informed consent to participate in an
RCT and allowed the limited disclosure to subjects of the
true purpose of the trial.
Inclusion and exclusion criteria
Selection of subjects was based on the hospital records
of mothers who met the study eligibility requirements
(Table 2). Further exclusions were made on a case-
by-case basis if an audit of the medical record revealed
that the mother was incarcerated, mentally incapaci-
tated, or the baby had been adopted or placed into fos-
ter care. Since infant (and maternal) deaths following a
mother’s discharge are not routinely captured in the
hospital’s patient management system, the South Aus-
tralian Births, Deaths and Marriages Registration Office
was engaged to conduct weekly searches to identify any
deaths which might have occurred prior to randomisa-
tion and, where identified, the mother was excluded
from the trial. Weekly searches for deaths continued
until parents exited the interview. The flow of subjects
in this study is shown in Figure 1.
Sample size
The primary outcome of interest was a comparison of
the parental participation rate in each arm. To detect an
effect size difference of 10% (assuming 80% in the
opt-out arm and 70% in the opt-in arm) using a two-
tailed test at the 5% level with power of 80% we required
313 subjects in each arm (total 626 subjects). A further
10% inflation allowed for the stratified design of rando-
misation for the pre-specified confounder of firstborn
status. Thus, the sample size for the primary outcome
required 344 subjects in each arm: a total of 688 subjects.
However, important secondary outcomes of interest
related to the recruitment of parents for the subsequent
telephone interview. The sample size required for the
secondary outcome was 544 subjects in each arm: a total
of 1,088 subjects.
Randomisation and blinding
The unit of randomisation was the mother who was
randomly allocated, by date order of confinement, to the
opt-in and opt-out arm in the ratio 1:1. The randomisa-
tion schedule was stratified by firstborn status (first live
and surviving birth versus subsequent births). It used
randomly permuted blocks of sizes 2, 4, 6 and 8 and
was created using the program ralloc [35] in Stata statis-
tical software [36]. We stratified on firstborn status
Table 2 Eligibility criteria and rationale
Criterion Rationale
Inclusion criteria
Mothers who had a live and surviving birth at the WCH. A birth must be viable and surviving to enable data linkage of immunisation
encounters at two months and hospital admissions after birth.
Mother’s age was equal or above 18 years. This is the age accepted by HRECs where informed consent can be given by an
individual.
Mother was a resident of SA. The data linkage will involve only South Australian children whose immunisation
encounters will be linked with admissions to a South Australian hospital. Cross-
jurisdictional migration will be unaccounted for i.e., if a family moves interstate
after the birth or an infant is admitted to an interstate hospital.
Exclusion criteria
Maternal death, stillbirth or neonatal death. In the instance of
twins or triplets, if one died, the mother was excluded.
To avoid causing distress to a bereaved family.
Infant stays in the NICU of 2 weeks or longer. To avoid causing distress to a family dealing with issues of infant illness and
prematurity.
Home births and births that occurred at other hospitals and
were subsequently managed at the WCH.
To ensure each mother had received the same type of care prior to discharge
and data were available in the hospital patient management system for all
variables of interest.
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safety, and their attitudes towards vaccination and vacci-
nation practices, could be influenced by previous experi-
ence of infant immunisation, especially if an adverse
event occurred following immunisation.
The trial was single-blinded: parents were unaware
that two types of consent were being compared, but
were aware of the data linkage study. Blinding was not
appropriate for the two researchers [JGB, JW] who
conducted interviews since the interview structure
required knowledge of whether the parent had, or had
not, returned the reply form. For the analysis and
reporting, the primary outcome will be assessed by one
researcher who will be blind to allocation.
Intervention and follow-up
All households received a cover letter (addressed to the
mother), an information leaflet and a reply-paid form,
with different formats according to allocation to the
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Figure 1 Flow diagram of opt-in compared with opt-out trial.
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invited parents to be part of a ‘Vaccine Data Linkage
Study’ in order to investigate data linkage as a new way
of checking for rare reactions to vaccines by looking at
large numbers of children. Parents were asked for per-
mission to link infants’ two-month vaccination records
with any hospital visits occurring in the month following
vaccinations. The study invitation was mailed after ran-
domisation at six weeks post-partum; its arrival was
timed to advise parents of the study one to two weeks
prior to the scheduled two-month vaccinations. Parents
in the opt-in arm were instructed to return a reply form
to signal willingness to participate in data linkage;
whereas parents in the opt-out arm were informed they
would be included unless they returned a reply form to
refuse consent. Telephone or email response was also
accepted. No follow-up reminder letters were sent, to
make the participation rate - the response to one invita-
tion - relevant to large population data linkage studies.
The cut-off time for data to be included in the estima-
tion of the participation rate at 10 weeks post-partum
included the first day of the 11th week to allow for
internal hospital postal delays, giving all parents four
weeks to respond. The telephone interview occurred
when infants reached 10 weeks of age, corresponding
with one to two weeks after administration of the two-
month vaccinations to enable data collection on vaccina-
tion practice and experience of adverse events.
Data management
All data collection and interviews occurred at the study
centre. A database was developed to manage the
study flow and follow-up of subjects, the mail-out of
study invitation material, and transcription of telephone
interview responses from paper booklets into electronic
format. All data were kept securely on a non-networked
computer. File back-ups and associated paperwork were
stored in a locked filing cabinet, as required by relevant
guidelines for the ethical conduct of research.
Outcome assessment
The primary outcome at 10 weeks post-partum was the
proportion of parental participation in each arm, as indi-
cated by the respective return or non-return of a reply
form (or via telephone or email response). Secondary
outcome data, including socio-demographic characteris-
tics, were captured from the hospital’sp a t i e n tm a n a g e -
ment system and at the subsequent telephone interview
at 10 weeks post-partum. These included: 1) the intervie-
wee’s age, gender, marital status, country of birth, main
language at home and level of education; 2) the mother’s
age, marital status, country of birth, Indigenous status
and firstborn status of the infant; and 3) the household
size, composition, annual income, Socio-Economic
Indexes For Areas (SEIFA) Index of Relative Socio-
Economic Disadvantage (IRSD) [37] and location (major
cities or other). The IRSD and location measures were
derived from postcode of usual residence.
The study invitation material and telephone survey were
designed and administered according to recommended
principles [38,39]. They were initially piloted on a small
number of academic staff, and then further modified and
refined through piloting on a convenience sample of 20
subjects similar to the study’s target group: parents of
young children. The pilot groups were re-utilised by the
study team for training purposes to develop skills in the
delivery of the telephone interview. The survey collected
information on the parent’s recall of the study and its pur-
pose, reasons for the return or non-return of the reply
form, consent preferences, understanding of data linkage
and the level of trust in its protection of privacy. The
survey also canvassed attitudes towards vaccination in
terms of its public health benefit, safety, and effectiveness;
vaccination practices; experiences of minor and serious
infant illness and the likelihood of being vaccine-related;
and socio-demographics measures. Questions relating to
consent preferences [20] and perceptions about the safety
and effectiveness of vaccines [20,40] were derived from
published telephone surveys to assist in comparison with
similar studies.
The interview schedule was designed to be pragmatic
to optimise response rates. While the researchers endea-
voured to interview the parent (either mother or father)
who had opted in or opted out as identified by name on
the reply form, this was not always possible even with
multiple call-backs. In such instances, the other parent,
if available, was interviewed as a proxy. For households
who neither opted in nor opted out, the interviewers
had no knowledge of which parent, if any, had read the
study invitation material. The first parent to answer the
telephone was invited, as there was no basis for prefer-
entially interviewing one parent over the other.
Analysis plan
All analyses will be performed on an intention-to-treat
basis. The primary outcome, consent to participate, will
be compared using a chi-square test, modified appropri-
ately (Mantel-Haenszel method) to account for the
permuted block randomisation. The Type I error level is
set at 0.05 (two-tailed). There are no pre-specified con-
founders for the primary analysis. Comparisons of
socio-demographic characteristics between those con-
senting in the two arms will use chi-square tests, t-tests
or Wilcoxon rank sum tests appropriate to the scale of
measurement. The secondary outcomes for the study
arms will be compared using simple tests (as above) and
adjusted for socio-demographic characteristics where
appropriate using generalised linear models. Missing
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either at random or completely at random, multiple
imputation will be used. A total of 50 imputed datasets
will be generated using the package mi in Stata statisti-
cal software [36]. Depending on the pattern of missing
values, we will use sequentialu n i v a r i a t ec o n d i t i o n a l
distributions or a multivariate normal method, using
socio-demographic and other background variables as
predictors. The quality of the imputations will be evalu-
ated by checking how reasonable the imputed data are
and testing the fit of the missing-data models.
Recruitment
Procurement of subject lists was straightforward and
timely, with exclusions readily identifiable from existing
data fields (Figure 1). Six ineligible mothers were
included in the trial as a result of recording errors in
the data fields (e.g., mothers whose infants had had an
extended Neonatal Intensive Care Unit (NICU) stay or
mothers who were non-residents of SA). An additional
five mothers included in the trial would have been
excluded had it been possible to audit all the medical
records prior to randomisation. Examples were mothers
who were incarcerated, mentally incapacitated, or whose
baby was placed into foster care. If the mother’s exigent
circumstances were discovered upon audit of the medi-
cal record (to follow-up returned mail or non-contacts
for the telephone interview), no further contact was
attempted.
Implementation of telephone interviews
Households were initially contacted on the day the
infant reached 10 weeks of age. A minimum of three
calls was made at varying times of the day (morning,
afternoon, evening) before a household was classified as
non-contactable. Interview recruitment was high: 1026
parents were interviewed (91%), of whom 925 (82%)
completed the interview and 101 (9%) partially com-
pleted the interview. A partially completed interview
was usually one where the parent answered one ques-
tion only: the reason why they did or did not return the
reply form. There were 57 non-contactable households
(5%) despite repeated attempts and a connected tele-
phone number. A further 13 households (1%) were non-
contactable due to disconnected or wrong telephone
numbers recorded in the hospital system, while 28 (2%)
were non-English speaking and 5 (< 1%) refused to be
interviewed.
Discussion
This is the first RCT of opt-in and opt-out parental con-
sent for a population-based childhood vaccine safety
surveillance program using data linkage. It featured a
parallel design, adequate power for the primary outcome
and thorough follow-up of subjects to determine atti-
tudes to consent, data linkage and other important
issues.
The comprehensive list of socio-demographic variables
included in the hospital’s patient management system
provided basic information on a range of socio-demo-
graphics for all mothers: age, marital status, country of
birth, Indigenous status, household location (major cities
or other) and IRSD. It will, therefore, be possible to
determine the presence of selection bias in the participa-
tion rate, irrespective of whether a subject answered the
socio-demographic questions in the interview. The pre-
vious RCTs of opt-in versus opt-out consent [26-30] did
not show such comparisons [26,27], or were restricted
by the small number of socio-demographic characteris-
tics for which data were available for all eligible patients:
either age and sex alone (which gave no insight) [28,30],
o ra g e ,s e xa n dt h eI R S D( w h i c hg a v el i m i t e di n s i g h t )
[29].
The recruitment rate for the interview was high for a
number of reasons. Firstly, SA Health’sd a t al i s t i n g s
recorded a mother’s mobile and landline telephone
number and often a spouse or de facto’s mobile number,
enabling parents to be contacted even if they had chan-
ged residence. Secondly, the interviewers were persistent
in the follow-up of returned mail and non-contacts for
the interview, and optimised contact through auditing
medical records to find valid residential addresses and
telephone numbers. Thirdly, parents usually had a good
rapport with the hospital as recent recipients of its
health services and were willing to participate in the
research for altruistic reasons.
This trial focused on parental attitudes towards using
data linkage in one context: childhood vaccine safety
surveillance. Although there will be some overlap in
motivators and barriers to participation, some impor-
tant determinants of participation among parents may
not be relevant for data linkage studies in other
health-related areas. The portfolio of evidence on the
public’s preferences for consent and attitudes towards
the intrinsic value of data linkage, levels of trust in its
protection of privacy in different population/patient
groups and in different health areas requires
expansion.
The cut-off time for data to be included in the esti-
mation of the participation rate was chosen ap r i o r ito
allow parents sufficient time to immunise their infants,
and for adverse events to be captured, and to balance
the potential for recall bias against potential for late
returns. Every parent had four weeks to respond to the
study invitation material and did not receive follow-up
reminders. Based on findings from previous surveys
[38,39], we anticipate that the number of parents who
opted in or opted out may be half those attained if
Berry et al. Trials 2011, 12:1
http://www.trialsjournal.com/content/12/1/1
Page 7 of 10follow-up mailings had been implemented. We accepted
reply forms that were received within a week of the
interview at 10 weeks post-partum, which prompted a
small number of crossovers. For example, a parent in
t h eo p t - i na r mm a yh a v ea n s w e r e di nt h ei n t e r v i e w
that they had been too busy to send back the reply
form, but the process of being interviewed reminded
them to do so. In this instance, it is unlikely the parent
would have returned the reply form of their own
volition.
The interviews may have been subject to respondent
bias, in that parents may not have honestly reported
motivations and barriers to the return or non-return of
reply forms in a telephone conversation with a ‘stran-
ger’ affiliated with the trial. While qualitative metho-
dology may be more successful in revealing true
motive, facilitated by developing rapport with inter-
viewers and/or focus group members through in-depth
exploration of reasons underlying participation and
non-participation, fewer parents could have been
studied in the same time.
We did not engage interpreter services for non-
English speakers. While the number of parents who had
no English comprehension was smaller than anticipated
(2%), we encountered parents with varying levels of Eng-
lish proficiency, ranging from the ability to comprehend
and answer a small number of questions in the inter-
view (usually only questions related to vaccinations
practices and episodes of infant illness) to answering all
questions, but with some uncertainty as to their under-
standing. The interviewers flagged the interviews in
which they perceived the parents’ English to be limited,
and this can be used as a covariate in the analysis, in
addition to the socio-demographic variables that provide
information on country of birth and main language spo-
ken at home.
Informed consent is generally regarded as an essential
component of health research. Low participation rates
in health and medical research can lead to selection bias
and compromise statistical precision. Therefore, consent
procedures should aim to reduce bias and improve par-
ticipation rates. VALiD is the first RCT to compare opt-
in with opt-out parental consent for a population-based
childhood vaccine safety surveillance program using
data linkage. This study fills a gap in the literature in
that it will not only assess the participation rate and
selection bias for each consent option but, through a
subsequent telephone interview of all households, will
also assess consent preferences and intent compared
with actual opting in and opting out behaviour, and
socioeconomic factors. The findings will have relevance
to all stakeholders and policy makers and will stimulate
public debate about what it means to protect patients’
interests.
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